Drug intelligence / Profile preview

OMNi-BiOTiC FLORA plus+

Development stage: Unknown
Lead developer: Institut AllergoSan
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

OMNi-BiOTiC FLORA plus+ is an oral probiotic supplement developed by Institut AllergoSan, specifically formulated to support and restore the female vaginal flora. It contains four scientifically validated bacterial strains: *Lactobacillus crispatus* LBV88, *Lactobacillus rhamnosus* LBV96, *Lactobacillus gasseri* LBV150, and *Lactobacillus jensenii* LBV116. These strains are natural inhabitants of a healthy vaginal environment. The product is designed to be taken orally, where the bacteria migrate from the intestinal tract to the vaginal area to colonize and maintain a low pH, thereby inhibiting the growth of pathogens such as *Gardnerella vaginalis* and *Candida albicans*. It is frequently recommended as an adjunct to antibiotic or antifungal therapy to prevent the recurrence of vaginal infections and restore microbial balance.

Brand names: OMNi-BiOTiC FLORA plus+
Other names: Omni-Biotic Flora Plus

Beyond the preview

Go deeper on OMNi-BiOTiC FLORA plus+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMNi-BiOTiC FLORA plus+.

Explore the full profile